Newcomers to the cpd

   NEWCOMERS TO THE CPD
Short biographies

Khosrow Adeli



Dr. Adeli is currently head and full professor of clinical biochemistry at the Hospital for Sick Children and the Departments of Biochemistry and Laboratory Medicine & Pathobiology at the University of Toronto in Toronto, Canada. Dr. Adeli is a fellow of the Canadian Academy of Clinical Biochemistry and detains a diploma of the American Board of Clinical Biochemistry.

Dr. Adeli is actively involved in basic and applied research on lipoprotein metabolism in insulin resistance for the last decade and has published over 190 articles and abstracts to date. His research program is focused on molecular biology of type 2 diabetes and insulin resistant states. His group has particularly focused on elucidating the molecular mechanisms linking diet-induced insulin resistance and metabolic dyslipidemia. Dr. Adeli served as the Editor-in-Chief of the Clinical Biochemistry journal for 7 years (1999-2006). He is currently an editorial board member of the Clinical Biochemist Reviews.

Dr. Adeli has received several national and international awards for research excellence including the Canadian Society of Clinical Chemistry National Award for outstanding contributions to clinical chemistry (2006), Canadian Academy of Clinical Biochemistry National Award (2004), the Canadian Society of Clinical Chemistry Research Excellence Award (1999), Bristol-Meyers Squib Young Investigator (1995), the Merck Senior Investigator Award (1997), and the Simon-Pierre Noel Award (2001) from the Canadian Lipoprotein Conference.

Dr. Adeli is also currently the President of COMACC, the Commission on Accreditation in Clinical Chemistry, a North American organization responsible for accreditation of clinical chemistry training programs in the USA and Canada.

Dr. Adeli has generously accepted to be appointed as Public Relations Coordinator and Vice-Chair of the CPD. We are assured that he will make important contributions in coordinating divisional activities at the IFCC-CPD as well as in establishing and coordinating public relations. His proposed initiatives related to promoting the international activities of the IFCC to the public, governmental organizations, as well as other medical specialties, will enhance the visibility of IFCC at all levels worldwide.


Hassan El-Sayed



Dr. El-Sayed is presently the Managing Director of the InfoTech Center and Advisor to the Syrian Virtual University in Damascus, Syria. He also is Information Technology (IT) consultant to the Syrian Clinical Laboratory Association (SCLA), scientific consultant to the Arab League Educational Cultural and Scientific Organization (ALESCO) and member of the expert team of the Arab World Open Source Project of ALECSO..

Dr. El-Sayed after receiving his Bachelor�s Degree in Applied Mathematics and Physics from the University of Damascus. He pursued his training first, at the Imperial College of Science and Technology in London, England where he obtained a Master�s degree in Applied Mathematics and Atmospheric Physics., and then at the University of Maryland, USA, where he completed a Ph.D. program in Applied Mathematics and Computer Sciences.

Dr. El-Sayed is proficient in designing and writing computer-based information systems for the scientific and business environment. He has long time experience in computer modeling and expert system design and implementation in several domains.
He is the founder of the Arabic-Computer-Assisted Translation Section at SYSTRAN Inc. located in La Jolla, California.

His mission statement is: �IT Literacy - No Lab Scientist is left behind�. He has set himself 3 goals that are paraphrased as: IT literacy to all, Improved knowledge and accessibility, and International reach-out to all working in the field of clinical Chemistry through the IFCC website.

His background and his past achievements warrant the success of his future endeavors within the IFCC CPD.


Edgard Delvin



Dr. Edgard Delvin is presently Chief of the Department of Clinical Biochemistry at the CHU Ste-Justine and Professor at the Department of Biochemistry of the Faculty of Medicine, University of Montreal.

Besides his clinical duties, Dr. Delvin has constantly been active in research holding grants from the Shriner�s Foundation and from the Canadian Institutes for Health Research. He has authored or co-authored over 140 papers in high-level international scientific journals and several book chapters. He has won the young investigator award from the Fonds de Recherche en sant� du Qu�bec and received the Canadian Society for Clinical Chemists award for excellence in research.

Dr. Delvin has received his Ph.D. in biochemistry from the University of Montreal. He pursued his training first as a post-doctoral fellow at the Institute Armand-Frappier in Immunochemistry and then in Biochemical Genetics at the Monteal Children�s Hospital at Mc Gill University.

In his mission statement, he has set himself goals of enhancing the perception of the Newsletter as a worldwide forum in which opinions are shared and discussed in a lively manner and of assuring a representation of all continents on IFCC eNewsletter working group he chairs.